Spruce Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $13.5M | $162.9M | $157.2M |
| FY2021 | $15.1M | $126.5M | $42.7M |
| FY2022 | $17.2M | $85.6M | $24.5M |
| FY2023 | $27.4M | $103.9M | $96.3M |
| FY2024 | $16.4M | $45.2M | $38.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $13.5M | $162.9M | $157.2M |
| FY2021 | $15.1M | $126.5M | $42.7M |
| FY2022 | $17.2M | $85.6M | $24.5M |
| FY2023 | $27.4M | $103.9M | $96.3M |
| FY2024 | $16.4M | $45.2M | $38.8M |